Brief: Helius Medical Technologies Announces FDA Breakthrough Device Designation
17/08/2021 12:07
Aug 17 (Reuters) - Helius Medical Technologies Inc HSDT.O :
* HELIUS MEDICAL TECHNOLOGIES, INC. ANNOUNCES FDA
BREAKTHROUGH
DEVICE DESIGNATION FOR THE TREATMENT OF DYNAMIC GAIT AND BALANCE
DEFICITS FOLLOWING A STROKE
Source text for Eikon: ID:nGNXbr9d51
Further company coverage: HSDT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Solana Co
See all newsBrief: Solana Co Pursuant To Prospectus Supplement, May Offer Shares Of Common Stock Of Up To $250 Million From Time To Time
Brief: Solana: On May 12, Dane C. Andreeff Resigns As CEO, President And Board Member
Solana Co Q1 revenue surges on staking rewards
Brief: Solana Company (Nasdaq Hsdt) Appoints Madelene Gani As Chief Operating Officer And Deputy CFO To Lead Next Phase Of Growth
Solana Co Q4 revenue surges on staking rewards, swings to profit